Proceedings of the 2020 4th International Seminar on Education, Management and Social Sciences (ISEMSS 2020)

Research on Compulsory Drug Patent Licensing in China Under Covid-19

Authors
Zhou Zhide, Yu Shanshan
Corresponding Author
Zhou Zhide
Available Online 28 August 2020.
DOI
10.2991/assehr.k.200826.082How to use a DOI?
Keywords
covid-19, drug patents, the compulsory license, the applicant, licensing procedures
Abstract

Covid-19 has spread in China and quickly spread to the world. The world health organization (WHO) has listed it as a public health emergency of international concern. In the face of this serious pandemic, global public security has been seriously threatened, and it is imperative to address the supply of medicines. This paper starts with the current situation of covid-19, compares the practice of compulsory drug patent licensing in different countries, and finds out the deficiency of compulsory drug patent licensing in China. Then put forward feasible suggestions for drug patent compulsory licensing.

Copyright
© 2020, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

Volume Title
Proceedings of the 2020 4th International Seminar on Education, Management and Social Sciences (ISEMSS 2020)
Series
Advances in Social Science, Education and Humanities Research
Publication Date
28 August 2020
ISBN
978-94-6239-048-5
ISSN
2352-5398
DOI
10.2991/assehr.k.200826.082How to use a DOI?
Copyright
© 2020, the Authors. Published by Atlantis Press.
Open Access
This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - CONF
AU  - Zhou Zhide
AU  - Yu Shanshan
PY  - 2020
DA  - 2020/08/28
TI  - Research on Compulsory Drug Patent Licensing in China Under Covid-19
BT  - Proceedings of the 2020 4th International Seminar on Education, Management and Social Sciences (ISEMSS 2020)
PB  - Atlantis Press
SP  - 415
EP  - 417
SN  - 2352-5398
UR  - https://doi.org/10.2991/assehr.k.200826.082
DO  - 10.2991/assehr.k.200826.082
ID  - Zhide2020
ER  -